Title : Phase I study of idarubicin dose escalation for remission induction therapy in acute myeloid leukemia.

Pub. Date : 2016 Oct

PMID : 26750985






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The maximum tolerated dose (MTD) of idarubicin should be reevaluated in the treatment of acute myeloid leukemia (AML) in the era of granulocyte colony-stimulating factor and better supportive care. Idarubicin colony stimulating factor 3 Homo sapiens